Demand for automated immunoassay analyzers surges across laboratories and clinics, driven by soaring test volumes and ...

Astute Analytica stands out as a premier provider of comprehensive Automated Immunoassay Analyzers market research reports specifically tailored for the healthcare sector. Our commitment lies in ...

Chemiluminescent Enzyme Immunoassay (CLEIA) represents a breakthrough in diagnostics, combining the unparalleled sensitivity of chemiluminescence and distinctive specificity.

The assay, which received FDA 510 (k) clearance in 2023 and IVDD certification in 2022, is intended for in vitro diagnostic use to aid in the diagnosis of inflammatory bowel disease (IBD ...

ALPCO Announces the European Commercial Launch of FDA 510 (k) Cleared Calprotectin Immunoturbidimetric Assay and Patient Enrollment in Pivotal US Clinical Trial for Automated Chemiluminescent Version ...

Anbio Biotechnology has launched its Dry Chemiluminescence Immunoassay Solution ADL-1000. The platform was developed to deliver rapid, reliable, and cost-effective diagnostic results, the ...

FRANKFURT, Germany, Jan. 9, 2025 /PRNewswire/ -- Anbio Biotechnology ("Anbio"), a global leader in diagnostics innovation, announces the launch of its Dry Chemiluminescence Immunoassay (CLIA ...

Researchers develop a novel chemiluminescent assay to study the responsiveness to programmed cell death protein 1 blockade therapy ...